SSA
ACHV icon

Schonfeld Strategic Advisors’s Achieve Life Sciences ACHV Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,389
Closed -$42.3K – 2560
2026
Q1 		$42.3K Buy
+14,389
New +$63.9K ﹤0.01% 1992
2022
Q2 		– Sell
-10,200
Closed -$77K – 2474
2022
Q1 		$77K Buy
+10,200
New +$76K ﹤0.01% 2280

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Schonfeld Strategic Advisors's ACHV Position: Q2 2026 in Review

Schonfeld Strategic Advisors sold out of Achieve Life Sciences (ACHV) in Q2 2026, closing a stake of 14,389 shares — an estimated $42.3K sold.

Schonfeld Strategic Advisors first reported a position in ACHV in Q1 2022 and held it in 2 quarters. The position peaked at $77K in Q1 2022. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Schonfeld Strategic Advisors reported no remaining Achieve Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 14,389 Achieve Life Sciences shares in Q2 2026, an estimated $42.3K.
  • Schonfeld Strategic Advisors first reported a position in Achieve Life Sciences in Q1 2022 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's Achieve Life Sciences position peaked at $77K in Q1 2022.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.